Glucagon is polypeptide hormone derived from pancreas which in addition to its metabolic actions has also certain cardiovascular stimulatory effects. We've explored the effects of glucagon on hemodynamic variables (mean arterial pressure, heart rate and central venous pressure) and on catecholamine level and the electrolite level in the kanine sera. It was estimated that glucagon expressed the positive chronotropic effect and significantly lowers the central venous pressure while inconsiderably inceases mean arterial blood pressure. It also leads to transient (short-lasting) hipokaliemia and nonsignificant hipocalcemia. As the result of the action of the glucagone, the serum adrenaline concentrations were significantly increased while the serum noradrenaline concentratios were significantly decreased
Y. T, S. A, S. G, H. G, O. O, M A. Gure A.: The effects of amrinone and glucagon on verapamil-induced myocardial depression in a rat isolated heart model. Gen Pharmacol. 28, 5:773–6.
2.
J.M. B, R.E R. Blazquez E.: Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. Am J Physiol. :266.
3.
R. B, A G. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Glucagon for the treatment of symptomatic beta blocker overdose. Emerg Med J. 20(3):266–7.
4.
Joye F. Beta-blocker intoxication. Presse Med. 29(18):1027–33.
5.
M.R. L, W.A P. Barret E.J.: The time course of myocardial glycogenolysis stimulated by glucagon. J Mol Cell Cardiol. 25, 2:175–83.
6.
T. O, M. E, M Y. Inoue S.: Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system. Peptides. 26(9):1623–31.
7.
S. S, M.H. T, N. O, H N. Milrinone versus glucagon: comparative hemodynamic effects in canine propranolol poisoning. J Toxicol Clin Toxicol. 32, 3:277–89.
8.
S. S, M.H. T, N. O, C. N, H N. Combined use of glucagon and milrinone may not be preferable for severe propranolol poisoning in the canine model. J Toxicol Clin Toxicol. 33(4):337–42.
9.
P. S, B G. Sauerbruch T.: Effects of different octreotide dosages on splanchnic hemodynamics and glucagon in patients with TIPS. Am J Gastroenterol. 96(7):2218–24.
10.
C.K. S, W.A M. Carroll R.: Treatment of verapamil overdose with glucagon in dogs. Ann Emerg Med. 25(3):369–74.
11.
A.E. T, J. W, W. V, Biesebeek J.D., J. M, Wildt D.J. Experimental study of the detrimental effect of dopamine/glucagon combination in d,l-propranolol intoxication. Hum Exp Toxicol. 15(5):411–21.
12.
13.
E. V, Y.J L. Gylfe E.: Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell. Naunyn Schmiedebergs Arch Pharmacol. 369(2):179–83.
14.
M.G. VP, J.M. E, X. W. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res. 89:445–52.
15.
H. Y, C.E. L, J.N. M. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest. 110:43–52.
16.
K. C, J. A, O.W G. The antiarrhythmic effects of glucagon in digitalis toxicity. Circulation. 3(60).
17.
F.W. W, T.N J. Chronotropic action of glucagon on the sinus node. Proc Soc Exp Biol Med. 122(823).
18.
A. F, R.J. T, Pharmacol. Exp. Ther. 49:129.
19.
M.R. L, W.A. P, E.J B. The time course of myocardial glycogenolysis stimulated by glucagon. J Mol Cell Cardiol. 25(2):175–83.
20.
S. S, M.H. T, N. O, H N. Milrinone versus glucagon: comparative hemodynamic effects in canine propranolol poisoning. J Toxicol Clin Toxicol.
21.
A.E. M, D.H V. Rogers R.J.: A comparative study of the effects of glucagon and catecholamines on cardiac performance in dogs. J Pharmacol Exp Ther. 203:303–11.
22.
J.E. M, S. SC, J.J F. Campbell T.: Glucagon’s action on myocardial function during beta-blocker overdose: a dose-response study. J Clin Pharmacol. 40(5):580–5.
23.
Lawrence-M.D AM. New ideas for an Old Hormone. Vol. 54.
24.
E. W, K.F W. The synthesis of Glucagon. Properties of Synthetic Glucagon. p.31 In: Glucagon, Molecular Physiology, clinical and Therapeutic implications.
25.
B.R L. Cardiac actions of glucagons. Circulat Res. 22(777).
26.
G.S. L, S.E E. Activation of adenyl cyclase by glucagons in cat and human heart. Circ Res. 24(151).
27.
E. S, D. MP, H. D, D. NP, Rice LBS. Effects of glucagons on cyclic 3’,5’-AMP, phosphorylase activity and contractility of heart muscle of the rat. Circ Res. 26(225).
28.
G. G, W.W. P, A.S. W, E.H S. Glucagon its enhancement of cardiac performance in cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol.
29.
L.F. S, C.D. W, A.S. V, J.G H. Adrenocortical medullary effects of glucagons. Amer J Physiol. 199:867–70.
30.
A.M. L, Glucagon A. 20:207–23.
31.
P.H. S, N.H B. Endocrinology. 87:111.
32.
L.V. A, S.J. B, S. S, W S. Role of the thyroid gland during glucagons-induced hypocalciemia in the dog. Amer J Physiol. 216:939–45.
33.
E. P, A.M. L, F.H. S, D. P, P.V. H, D.V C. Alpha cell hyperplasia in calcific pancreatitis associated with hyperparathyreoidism. JAMA. 200:757–61.
34.
J.B C. Delayed manifestation of the physiologic effects on insulin following administration of certain pancreatic extracts. Amer J Physiol. 63:391–2.
35.
A. G, J.R. W, G.F C. Studies on the perfused rat liver.: Effect of glucagons on gluconeogenesis. Diabetes. 15:188–93.
36.
S.L. M, V.E. C, G.M B. Texter E.C.: The Effects of glucagon on the superior mesenteric vascular bed. Fed Proc. 1:200.
37.
W.W. P, G G. Sonnenblick E.H.: Cardiovascular Effects of Glucagon in Man. New Eng Med. 1968(279):12.
38.
J.H. M, W.W. P, J.M. M. Effects of glucagon on myocardial oxygen consumption and coronary blood flow in man and in dog. Circulation. 41(579).
39.
K.E. C, J. A, O.W G. The effects of glucagons on arrhythmias due to digitalis. Amer J Cardiol. 25(683).
40.
R.D. W, D.B. P, J.K P, Patterson C. W.: A possible mechanism of the antiarrhythmic action of glucagons. Europ J Pharmacol. 44(57).
41.
J.I. L, D.M. K, E. D, C.K F. The electrophysiological properties of glucagon on the normal canine heart. Amer J Physiol. 5:1107.
42.
J.I. L, D.M. K, E D. The electrophysiologic properties of glucagon on the normal canine heart. Am J Cardiol. 23:123.
43.
J.M. B, J. E, R. R. Neural contribution to the effect of glucagons-like peptide (736) amide on arterial blood pressure in rats. Am J Physiol. :277.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
